Published in Ned Tijdschr Geneeskd on February 24, 1996
[Severe poisoning by 4-aminopyridine in a body builder]. Ned Tijdschr Geneeskd (1995) 1.44
Hand-held myometry: reference values. J Neurol Neurosurg Psychiatry (1991) 1.71
Anti-acetylcholine receptor antibodies in myasthenia gravis. Part 1. Relation to clinical parameters in 250 patients. J Neurol Sci (1983) 1.69
Rheumatic diseases in patients with myasthenia gravis. An epidemiological and clinical investigation. Acta Neurol Scand (1968) 1.65
[Use of alternative treatments by patients with myasthenia gravis]. Ned Tijdschr Geneeskd (1994) 1.64
Measuring muscle strength. J Neurol (1984) 1.52
Effect of prednisolone on neuromuscular blocking in mice in vivo. Neurology (1975) 1.49
Myasthenia gravis, autoantibodies, and HL-A antigens. Br Med J (1974) 1.47
[Favorable results of plasmapheresis in severe myasthenia gravis]. Ned Tijdschr Geneeskd (1997) 1.39
[Study of muscular strength in clinical practice]. Ned Tijdschr Geneeskd (1995) 1.37
Studies on sera from cases of myasthenia gravis, using the fluorescent antibody technique. Vox Sang (1967) 1.28
Permanent muscle weakness in familial hypokalaemic periodic paralysis. Clinical, radiological and pathological aspects. Brain (1990) 1.24
The average visual response in patients with cerebrovascular disease. Electroencephalogr Clin Neurophysiol (1969) 1.20
The "make/break test" as a diagnostic tool in functional weakness. J Neurol Neurosurg Psychiatry (1991) 1.19
Myasthenia gravis: diagnosis and follow-up of 100 consecutive patients. J Neurol (1997) 1.17
Curare sensitivity and myastheniform symptoms in patients with rheumatoid arthritis. Acta Rheumatol Scand (1969) 1.14
Observations of the natural history of myasthenia gravis and the effect of thymectomy. Ann N Y Acad Sci (1981) 1.08
The ocular signs and symptoms of myasthenia gravis. Doc Ophthalmol (1982) 1.06
The mean duration of motor unit action potentials in patients with myasthenia gravis. Electroencephalogr Clin Neurophysiol (1972) 1.05
HL-A antigens, autoantibody production, and associated diseases in thymoma patients, with and without myasthenia gravis. Ann N Y Acad Sci (1976) 1.01
The clinical spectrum of limb girdle muscular dystrophy. A survey in The Netherlands. Brain (1996) 0.98
The muscle fiber conduction velocity and power spectra in familial hypokalemic periodic paralysis. Muscle Nerve (1988) 0.97
Muscle antibodies in myasthenic mothers and their babies. Lancet (1966) 0.96
Myasthenia gravis. A survey. Clin Neurol Neurosurg (1981) 0.96
Anti-acetylcholine receptor antibodies in myasthenia gravis. Part 2. Clinical and serological follow-up of individual patients. J Neurol Sci (1983) 0.95
Cerebrotendinous xanthomatosis (CTX): a clinical survey of the patient population in The Netherlands. Clin Neurol Neurosurg (1987) 0.93
Muscle pathology, thymoma, and immunological abnormalities in patients with myasthenia gravis. J Neurol Neurosurg Psychiatry (1968) 0.92
Familial hypokalemic periodic paralysis. Clinical, diagnostic and therapeutic aspects. J Neurol Sci (1994) 0.88
Capillary gas chromatographic determinations of urinary bile acids and bile alcohols in CTX patients proving the ineffectivity of ursodeoxycholic acid treatment. Clin Chim Acta (1984) 0.88
Measurement of the handcoordination. Clin Neurol Neurosurg (1990) 0.88
Studies in myasthenia gravis. 2. The relation of some clinical and immunological data. J Neurol Sci (1968) 0.87
Influence of adult thymectomy on immunocompetence in patients with myasthenia gravis. J Immunol (1980) 0.86
Thymectomy in myasthenia gravis. A review. Ital J Neurol Sci (1983) 0.85
Myasthenia gravis on the Dutch antilles: an epidemiological study. Clin Neurol Neurosurg (2000) 0.84
Antibodies to acetylcholine receptor in patients with thymoma but without myasthenia gravis. Neurology (1980) 0.84
Changes in human T lymphocytes after thymectomy and during senescence. J Clin Immunol (1982) 0.83
Intractable ventricular tachycardia in a patient with giant cell myocarditis, thymoma and myasthenia gravis. Int J Cardiol (1986) 0.82
Autoantibodies and myasthenia gravis: epithelial cells of the thymus. Ann N Y Acad Sci (1966) 0.82
Improvement of muscle strength in familial hypokalaemic periodic paralysis with acetazolamide. J Neurol Neurosurg Psychiatry (1988) 0.81
Anti-acetylcholine receptor antibodies decrease after thymectomy in patients with myasthenia gravis. Clinical correlations. J Autoimmun (1991) 0.81
Antibodies to skeletal muscle in myasthenia gravis. Part 1. Diagnostic value for the detection of thymoma. J Neurol Sci (1993) 0.79
Anti-acetylcholine receptor antibodies in myasthenia gravis. Part 3. The effect of thymectomy. J Neurol Sci (1985) 0.79
[Quantification and evaluation of 5 neurological equilibrium tests in test subjects and patients]. Ned Tijdschr Geneeskd (1996) 0.79
The effect of low-frequency electrical stimulation on denervation atrophy in man. Scand J Rehabil Med (1987) 0.78
Potassium channels in hypokalaemic periodic paralysis: a key to the pathogenesis? Clin Sci (Lond) (1993) 0.78
Vibration perception threshold, complaints and sensory examination in diabetic patients. Acta Neurol Scand (1991) 0.78
Myasthenia gravis and Werlhof's disease. Acta Med Scand (1979) 0.78
Segregation of HLA haplotypes in 100 families with a myasthenia gravis patient. J Immunogenet (1977) 0.77
Azathioprine in myasthenia gravis: observations in 41 patients and a review of literature. Neuromuscul Disord (1991) 0.77
In vitro T-cell dependent B-cell activity in myasthenia gravis. Clin Exp Immunol (1985) 0.77
[On motor end-plate diseases with special reference to myasthenia gravis]. Verh Dtsch Ges Inn Med (1965) 0.76
Potassium and sudden death. Lancet (1991) 0.75
Ca-tension relationships of muscle fibers from patients with periodic paralysis. Muscle Nerve (1993) 0.75
[Physical examination--measurement of muscle strength]. Ned Tijdschr Geneeskd (2001) 0.75
[A series of articles on the usefulness and uselessness of physical diagnostics; comment]. Ned Tijdschr Geneeskd (1999) 0.75
Antibodies to acetylcholine receptors in myasthenia gravis. In vitro synthesis by peripheral blood lymphocytes before and after thymectomy. Clin Exp Immunol (1992) 0.75
[ Stroke, as such, does not exist]. Ned Tijdschr Geneeskd (1992) 0.75
Long-term effect of glucocorticosteroids on neuromuscular blocking in mice. J Neurol Neurosurg Psychiatry (1977) 0.75
[Medical decision making; pro or con?]. Ned Tijdschr Geneeskd (1984) 0.75
[Respiratory insufficiency in myasthenia gravis]. Ned Tijdschr Geneeskd (1985) 0.75
Failure of stapedius reflexometry in the diagnosis of myasthenia gravis. Ann Neurol (1985) 0.75
[The effect of thymectomy in patients with myasthenia gravis without thymoma; a statistical analysis]. Ned Tijdschr Geneeskd (1991) 0.75
[The thymus gland and myasthenia gravis]. Ned Tijdschr Geneeskd (1991) 0.75
[Unterberger's test not useful in testing of vesitibular function]. Ned Tijdschr Geneeskd (1994) 0.75
Current views on the treatment of myasthenia gravis: with particular reference to immunological mechanisms. Electroencephalogr Clin Neurophysiol Suppl (1978) 0.75
The effect of aldactone-A on intracellular potassium in patients with myasthenia gravis. J Neurol Sci (1973) 0.75
[A curable muscular disease]. Ned Tijdschr Geneeskd (1976) 0.75
[Myasthenia gravis, an autoimmune disease?]. Ned Tijdschr Geneeskd (1971) 0.75
[Histological picture of the thymus in relation to the result of thymectomy in myasthenia gravis]. Ned Tijdschr Geneeskd (1974) 0.75
Thymus-dependent serum factor in nonthymectomized and thymectomized patients with myasthenia gravis. Clin Immunol Immunopathol (1980) 0.75
[Treatment and nursing care of patients with myasthenia gravis]. Tijdschr Ziekenverpl (1976) 0.75
Antibodies to skeletal muscle in myasthenia gravis. Part 3. Relation with clinical course and therapy. J Neurol Sci (1993) 0.75
Factors influencing the relapse risk at steroid dose reduction in myasthenia gravis. Clin Neurol Neurosurg (1987) 0.75
[Myasthenia gravis; clinical aspects, pathophysiology and treatment]. Ned Tijdschr Geneeskd (1983) 0.75
Human sensitivity to small doses of d-tubocurarine. Neurology (1969) 0.75
Epidural haematoma. A retrospective study of 100 patients. Clin Neurol Neurosurg (1975) 0.75
[Immunological findings in patients with myasthenia gravis (MG)]. Ned Tijdschr Geneeskd (1976) 0.75
Antibodies to skeletal muscle in myasthenia gravis. Part 2. Prevalence in non-thymoma patients. J Neurol Sci (1993) 0.75
HLA type is not indicative for the effect of thymectomy in myasthenia gravis. J Neuroimmunol (1992) 0.75
RISA cisternography as a routine procedure in neurological patients. J Neurol Sci (1971) 0.75